clinical trial · NCT01796795
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Common WartVehicle gelSR-T100 gel with 1.0% of SMSR-T100 gel with 2.3% of SM
brief summary
This phase II study is to evaluate the efficacy of SR-T100 gel in complete clearance of target warts at different concentrations (1.0% and 2.3% of SM in Solanum undatum plant extract) in patients with CW.
started
Sep 1, 2030
primary completion
Apr 1, 2033
completion
Aug 1, 2033
last updated
Sep 14, 2023
official title
A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol